Nephros (NEPH) EV to EBITDA (2010 - 2026)

Nephros has reported EV to EBITDA for 17 years, with the latest figure at 28.09 in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 81.8% year-over-year to 28.09 in Q2 2026; TTM through Jun 2026 was 20.75, a 27.53% decrease from a year earlier, with the FY2025 full-year figure at 40.61, down 97.92% from the prior year.
• EV to EBITDA was 28.09 for Q2 2026 at Nephros, down from 291.71 in the prior quarter.
• The five-year high for EV to EBITDA was 2585.78 in Q4 2025, with the low at 97.29 in Q1 2024.
• Average EV to EBITDA over 5 years is 164.35, with a median of 11.75 recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: EV to EBITDA tumbled 688.89% in 2023, then jumped 6881.63% in 2025.
• Over 5 years, EV to EBITDA stood at 16.69 in 2022, then tumbled by 196.96% to 49.57 in 2023, then jumped by 174.71% to 37.04 in 2024, then surged by 6881.63% to 2585.78 in 2025, then tumbled by 98.91% to 28.09 in 2026.
• The last three EV to EBITDA figures came in at 28.09 (Q2 2026), 291.71 (Q1 2026), and 2585.78 (Q4 2025), per Business Quant data.